ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,376Medicare Part D Prescriptions Filled, Including Refills

Rank: 129 out of 890

$615K Total Retail Price of All Prescriptions

Rank: 187 out of 890

730 Patients Receiving at Least One Drug in Part D
73%Patients 65 Years and Older
67% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 730 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

20% of this provider’s 730 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

5% of this provider’s 10,350 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
HYDROCODONE-ACETAMINOPHEN 724 453 S3 1 3
LISINOPRIL 582 455 2 4
FUROSEMIDE 398 328 3 7
SIMVASTATIN 398 344 3 5
OMEPRAZOLE 386 313 5 8
POTASSIUM CHLORIDE 306 264 6 11
LEVOTHYROXINE SODIUM 285 245 7 2
HYDROCHLOROTHIAZIDE 279 216 8 9
AMLODIPINE BESYLATE 277 225 9 1
ATORVASTATIN CALCIUM 267 231 10 13
CIPROFLOXACIN HCL 244 189 11 58
CLONIDINE HCL 242 183 12 35
METFORMIN HCL 239 190 13 6
NEXIUM 228 141 14 14
MELOXICAM 227 197 15 18
AZITHROMYCIN 211 143 16 37
JANUVIA 198 171 17 59
TRAMADOL HCL 183 161 18 16
DICLOFENAC SODIUM 167 144 19 96
ATENOLOL 160 124 20 23
ZOLPIDEM TARTRATE 152 115 21 19
AMITRIPTYLINE HCL 151 93 R 22 43
METOPROLOL TARTRATE 136 117 23 15
LISINOPRIL-HYDROCHLOROTHIAZIDE 136 85 23 21
DIOVAN 131 122 25 33
TAMSULOSIN HCL 127 102 26 32
CARBINOXAMINE MALEATE 118 94 R 10 27 296
SERTRALINE HCL 117 101 28 26
TIZANIDINE HCL 108 79 29 106
NIFEDIPINE ER 98 83 30 75
CLOPIDOGREL 95 71 31 28
LIPITOR 95 81 31 77
ALLOPURINOL 94 80 33 31
DONEPEZIL HCL 92 91 34 30
GABAPENTIN 89 57 35 12
NAPROXEN SODIUM 87 62 36 223
PRAVASTATIN SODIUM 86 65 37 10
DIGOXIN 86 58 37 65
GLYBURIDE-METFORMIN HCL 84 76 R 39 115
CRESTOR 83 69 40 25
GLYBURIDE 82 68 R 41 83
AMLODIPINE BESYLATE-BENAZEPRIL 81 73 42 41
WARFARIN SODIUM 79 70 43 24
METOPROLOL SUCCINATE 78 63 44 17
PLAVIX 76 55 45 42
CARVEDILOL 76 68 45 22
VENLAFAXINE HCL ER 73 66 47 114
CYCLOBENZAPRINE HCL 70 18 R 48 64
AGGRENOX 65 57 49 219
ADVAIR DISKUS 63 47 50 52
TERAZOSIN HCL 63 55 50 142
DOXYCYCLINE HYCLATE 62 50 52 89
PANTOPRAZOLE SODIUM 60 32 53 34
MEGESTROL ACETATE 60 52 R 53 92
PREMARIN 59 29 R 55 105
DIOVAN HCT 59 56 55 48
LANSOPRAZOLE 57 45 57 171
INDOMETHACIN 57 29 R 57 275
JANUMET 55 35 59 194
ESCITALOPRAM OXALATE 55 22 59 51
HYDRALAZINE HCL 50 38 61 100
FLUCONAZOLE 50 36 61 155
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 3, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.